Home > Newsletters > International Medical Device Regulatory Monitor > Device User Fee Hearing Focuses on U.S. FDA Review Times
International Medical Device Regulatory Monitor
March 2012 | Vol. 20 No. 3
Device User Fee Hearing Focuses on U.S. FDA Review Times
Lawmakers on both sides of the aisle hammered the U.S. Food and Drug Administration’s (FDA) failure to reduce device approval times, with at least one lawmaker saying he would end the user fee program if “significant reforms” aren’t undertaken.
ePublishing :: CMS, Hosting & Web Development | © Copyright by FDAnewsAll rights reserved. Do not duplicate or redistribute in any form.